Ocular Therapeutix, Inc. (NASDAQ:OCUL)

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular Therapeutix, Inc. is headquartered in Bedford, Massachusetts.

Ocular Therapeutix, Inc. (NASDAQ:OCUL)’s Financial Overview

Ocular Therapeutix, Inc. (NASDAQ:OCUL) declined -5.49% yesterday to close its trading session at $9.29. The company has 1 year Price Target of $29.4. Ocular Therapeutix, Inc. has 52-Week high of $14.5 and 52-Week Low of $4.04. The stock touched its 52-Week High on Apr 22, 2016 and 52-Week Low on Aug 3, 2016. The stock traded with the volume of 1.57 Million shares yesterday. The firm shows the market capitalization of $231.14 Million.

Ocular Therapeutix, Inc. (NASDAQ:OCUL) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $-0.39/share against the analyst consensus estimate of $-0.5/share. The difference between the actual and expected EPS is $0.11 a share with a surprise factor of 22%.

The firm is trading with SMA20 of 17.01 Percent, SMA50 of 29.02 Percent and SMA200 of 16.87 percent. Ocular Therapeutix, Inc. has P/S value of 128.41 while its P/B value stands at 3.7. Similarly, the company has Return on Assets of -44.4 percent, Return on Equity of -56.2 percent and Return on Investment of -36.4 Percent. The company shows Gross Margin and Operating Margin of 77.5 percent and 0 percent respectively.

Many brokerage firms are involved in issuing their ratings on Ocular Therapeutix, Inc. (NASDAQ:OCUL). On 11-Aug-16 JMP Securities Initiated Ocular Therapeutix, Inc. Stock  to Mkt Outperform. Another firm also rated the stock on 17-Feb-16 where Morgan Stanley Upgrade the stock to Overweight.

The Stock currently has Analyst’ mean Recommendation of 1.8 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 5 analysts offering 12-month price forecasts for Ocular Therapeutix Inc have a median target of 21.00, with a high estimate of 60.00 and a low estimate of 16.00. The median estimate represents a +126.05% increase from the last price of 9.29.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Suncor Energy Inc. (NYSE:SU)

SUNCOR ENERGY is a world leader in mining and extracting crude oil from the vast oil sands deposits of northern Alberta. They also explore for, develop and market natural gas, operate a refining and marketing business in Ontario, and are actively involved in the development of renewable energy sources to help meet the energy needs of tomorrow.

Suncor Energy Inc. (NYSE:SU)’s Financial Outlook

The 22 analysts offering 12-month price forecasts for Suncor Energy have a median target of 34.68, with a high estimate of 40.00 and a low estimate of 23.71. The median estimate represents a +8.86% increase from the last price of 31.86.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Suncor Energy Inc. has a Consensus Recommendation of 1.82. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock gained 6.13% and closed its last trading session at $31.86. The company has the market capitalization of $53.06 Billion. The stock has 52-week high of $32.42 and 52-Week low of $18.71. The firm touched its 52-Week high on Nov 30, 2016 and 52-Week low on Jan 20, 2016. The company has volume of 6.1 Million shares. The company has a total of 1.67 Billion shares outstanding.

Suncor Energy Inc. (NYSE:SU) in the last quarter reported its actual EPS of $0.21/share where the analyst estimated EPS was $0.09/share. The difference between the actual and Estimated EPS is $0.12. This shows a surprise factor of 133.3 percent.

The company has YTD performance of 26.6 percent. Beta for Suncor Energy Inc. stands at 1.09 while its ATR (average true range) is 0.93. The company has Weekly Volatility of 2.27%% and Monthly Volatility of 2.39%%.

Suncor Energy Inc. has distance from 20-day Simple Moving Average (SMA20) of 4.98%, Distance from 50-Day Simple Moving Average of 9.63 percent and Distance from 200-Day Simple Moving Average of 16.48%.

The Company currently has ROA (Return on Assets) of -2.5 percent, Return on Equity (ROE) of -4.9 Percent and Return on Investment (ROI) of -0.3% with Gross margin of 60.2 percent and Operating & Profit margin of -12.7% and -8.3% respectively.